Navigation Links
As Lipitor Lawsuits Progress, Bernstein Liebhard LLP Notes Publication of New Study Linking Statins to Cataract Development
Date:12/6/2014

(PRWEB) December 06, 2014

As hundreds of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the medication caused Type 2 diabetes move through federal court, Bernstein Liebhard LLP notes the publication of a new study linking statins to the development of another serious side effect. According to a report from HealthDay News, Canadian researchers have revealed that the use of Lipitor and other statins may increase the risk for cataracts, a vision disorder that causes the lens of the eye to become cloudy.*

The study, which appears in the December issue of the Canadian Journal of Cardiology, looked at more than 207,000 adults with cataracts and more than 1.1 million without them. The research team found that patients who had taken statins for a year could face as much as a 27% increased risk for cataracts compared to those who did not use the medications. According to HealthDay News, the lead author of the study said that additional clinical trials are necessary to determine if, in fact, statins can cause cataracts.

"This research just serves to remind that statins may be associated with some serious health consequences, especially in light of the litigation involving Lipitor and diabetes that is currently underway in federal court,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Diabetes Litigation
Court documents indicate that more than 1,400 Lipitor lawsuits have been filed in a federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, all of which accuse Pfizer Inc. of concealing information about the drug’s association with diabetes in order to protect sales of the medication. According to court documents, plaintiffs further allege that they would not have used Lipitor, or would have been more closely monitored for diabetes, had Pfizer’s warnings been sufficient. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

The litigation involving Lipitor and diabetes has been growing since February 2012, when the U.S. Food & Drug Administration (FDA) announced that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The FDA announcement followed the publication of a study in JAMA: Internal Medicine the previous month which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. **

Type 2 diabetes patients who allegedly developed the disease due to their use of Lipitor may be able to pursue their own case against Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*consumer.healthday.com/eye-care-information-13/cataracts-health-news-116/could-your-daily-statin-raise-your-risk-for-cataracts-694356.html, HealthDay News, December 5, 2014
**archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12376616.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes New Study Suggesting a Possible Alternative to Cholesterol-Lowering Statins
2. Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports
3. Lipitor Lawsuits Move Forward, as Pfizer Seeks Dismissal of Texas Diabetes Claims Pending in Multidistrict Litigation, Bernstein Liebhard LLP Reports
4. As Lipitor Lawsuits Move Forward, Bernstein Liebhard LLP Notes New Study Suggesting an Association Between Type 2 Diabetes and Stain Use
5. Lipitor Lawsuit News: New Case Management Order Issued in Federal Lipitor Litigation, Bernstein Liebhard LLP Reports
6. Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
7. South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports
8. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Type 2 Diabetes Claims in Federal Lipitor Litigation
9. Lipitor Lawsuits Continue to Be Filed in South Carolina Litigation, Bernstein Liebhard LLP Reports
10. Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial
11. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Milwaukee, WI (PRWEB) , ... March 29, 2017 , ... ... as its exclusive provider of co-op eligible dealer websites for its network of more ... line of professional landscaping and agricultural equipment including rotary and flail mowers and cutters, ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... professional squash, announced it has enlisted New York City-based sports and entertainment marketing ... develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes ...
(Date:3/29/2017)... ... March 30, 2017 , ... Grass pollen is the main cause of hay fever in ... The season for grass pollen runs from May to July each year; with the worst ... to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass ...
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
(Date:3/29/2017)... , ... March 30, 2017 , ... Sports Brand EXOUS ... brace, which retails normally at $29.97; for the remaining days of March, the price ... been reduced to a special price of just $10 (regular retail price $19.97). , ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... report to their offering. ... The global gas chromatograph market to grow at a ... report, Global Gas Chromatograph Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:3/29/2017)... March 29, 2017  BioSpecifics Technologies Corp. (NASDAQ: ... to develop collagenase based-therapies with a first in ... as XIAFLEX ®  in the U.S. and Xiapex ... a corporate overview at the upcoming 16 th ... 5, 2017 at 8:00 a.m. ET in ...
(Date:3/29/2017)... , March 29, 2017 Today, CVS Health ... Kim Reynolds , Department of Public Health Director ... Steve Lukan in announcing the availability of the ... Pharmacy locations in Iowa.  CVS Health has established a standing ... allows CVS Pharmacy to expand access to the medication in ...
Breaking Medicine Technology: